Pediatrics · Minneapolis, MN
NPI
1588735005
Since 2006
Specialty
Pediatrics
Code 208000000X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
University of Minnesota Physicians, 516 Delaware Street SE, Room 4-100
Minneapolis, MN, 55455
Phone (612) 626-6777
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,203
33 services
Medicare patients, 2024
26
Average age 58
Drug cost, 2024
$6.1M
258 prescriptions
Company payments, 2025
$22K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Chester B Whitley was code 99214 (office e&m - established), 24 times for 20 patients. In total Chester B Whitley billed 33 services in 4 codes, and Medicare paid $3,203.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-04-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 24 | 20 | $91.19 | $2,189 |
By year: 2022 $1,312 for 20 services; 2023 $2,442 for 31 services; 2024 $3,203 for 33 services.
Medicare prescription drug claims, 2024
In 2024, the drug Chester B Whitley prescribed most often to Medicare patients was Fabrazyme (Agalsidase Beta), with 58 prescriptions and refills. In total Chester B Whitley wrote 258 Medicare prescriptions that cost $6.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fabrazyme Agalsidase Beta | 58 | 58 | Under 11 | $626K |
| Galafold Migalastat Hcl | 39 | 57 | Under 11 | $1.8M |
| Sapropterin Dihydrochloride Generic | 31 | 31 | Under 11 | $234K |
| Nexviazyme Avalglucosidase Alfa-Ngpt | 23 | 23 | Under 11 | $1.4M |
| Procysbi Cysteamine Bitartrate | 16 | 16 | Under 11 | $1.4M |
| Palynziq Pegvaliase-Pqpz | 14 | 14 | Under 11 | $400K |
| Famotidine Generic | 13 | 13 | Under 11 | $127 |
| Opfolda Miglustat | 11 | 11 | Under 11 | $1,504 |
Brand drugs: 189 claims; generic drugs: 69 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Chester B Whitley $22K ($22K in general payments such as food, travel and fees) from 4 companies. The largest payer was Chiesi USA, Inc. with $22K.
| Company | Payments | Amount |
|---|---|---|
| Chiesi USA, Inc. | 2 | $22K |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.